MedPath

Assistance Publique des Hôpitaux de Paris SA

Assistance Publique des Hôpitaux de Paris SA logo
🇫🇷France
Ownership
Private
Established
1849-01-01
Employees
10K
Market Cap
-
Website
http://www.aphp.fr

Cystic Fibrosis and Totally Implantable Vascular Access Devices

Phase 4
Completed
Conditions
Cystic Fibrosis
Venous Thrombosis
Interventions
Device: totally implantable vascular access device
First Posted Date
2005-10-26
Last Posted Date
2011-08-29
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
97
Registration Number
NCT00244270

FROST 4: Study of the Optimal Spreading of a Coronary Stent Guided With Pressure Into the Coronary Arteries

Not Applicable
Completed
Conditions
Coronary Artery Insufficiency
Interventions
Procedure: Intra coronary measures of pressure
First Posted Date
2005-10-21
Last Posted Date
2011-11-29
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
800
Registration Number
NCT00242892
Locations
🇫🇷

European Georges Pompidou's Hospital, Paris, France

Functional Magnetic Resonance Imaging (fMRI) Study of Memory in Children

Completed
Conditions
Childhood Absence Epilepsy [Pyknolepsy]
First Posted Date
2005-10-21
Last Posted Date
2011-05-02
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
52
Registration Number
NCT00242905
Locations
🇫🇷

Service Hospitalier Frédéric Joliot (SHFJ), Orsay, France

🇫🇷

Necker Hospital, Paris, France

PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Interventions
Drug: Fluoro-L-thymidine-(18F)
First Posted Date
2005-10-12
Last Posted Date
2011-05-02
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
60
Registration Number
NCT00236275
Locations
🇫🇷

Hôpital TENON, Paris, France

Safety and Efficacy Study of Intravenous Lidocaine After Colorectal Surgery: LIDOREHAB

Phase 3
Completed
Conditions
Colorectal Neoplasms
First Posted Date
2005-10-12
Last Posted Date
2011-02-18
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
110
Registration Number
NCT00236249
Locations
🇫🇷

Hôpital Saint-Antoine, Paris, France

Effect of Positive Expiratory Pressure on Right Ventricular Function in Patients With Respiratory Distress Syndrome

Not Applicable
Completed
Conditions
Respiratory Distress Syndrome, Adult
First Posted Date
2005-10-12
Last Posted Date
2007-03-26
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
15
Registration Number
NCT00236262
Locations
🇫🇷

HOPITAL HENRI MONDOR Department of Neurosurgery, Creteil, France

Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers

Phase 3
Terminated
Conditions
Healthy Symptomatic Menopausal Women
Interventions
Drug: placebo
Drug: CLIMASTON (drug)
Drug: 17 Beta-estradiol (2mg/day)and (1mg/day)
First Posted Date
2005-10-12
Last Posted Date
2008-01-17
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
99
Registration Number
NCT00236301
Locations
🇫🇷

CIC, Saint Antoine Hospital, Paris cedex 12, France

Aortic Arch Related Cerebral Hazard Trial (ARCH)

Phase 3
Completed
Conditions
Brain Infarction
Transient Ischemic Attack
Embolism
Interventions
Drug: Clopidogrel-aspirin
First Posted Date
2005-10-10
Last Posted Date
2012-07-10
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
350
Registration Number
NCT00235248
Locations
🇦🇺

National Stroke Research Institute-Austin Health, Heidelberg Heights, Australia

🇫🇷

Bichat Hospital Head of Neurology Department, Paris, France

Adjustment of DOses of NIcotine in Smoking Cessation (ADONIS)

Phase 4
Completed
Conditions
Smoking Cessation
Interventions
Procedure: Dose adjustment of nicotine replacement therapies
First Posted Date
2005-10-10
Last Posted Date
2008-04-01
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
300
Registration Number
NCT00235313
Locations
🇫🇷

Groupe Hospitalier Pitié-Salpétrière, Unité de Recherche Clinique, Paris, France

High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II

Phase 2
Completed
Conditions
Testicular Neoplasms
Interventions
Procedure: high-dose and autologous stem cell transplantation
First Posted Date
2005-10-04
Last Posted Date
2011-02-25
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
50
Registration Number
NCT00231582
Locations
🇫🇷

Hôpital TENON, Service d'Oncologie Médicale, Paris, France

© Copyright 2025. All Rights Reserved by MedPath